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Abstract
Potassium permanganate (KMnO4) and potassium peroxymonosulfate (Oxone®) are chemical
oxidants widely used in natural surface waters and wastewaters for the control and removal of
pathogens and the prevention of disease caused by bacteria. However, KMnO4 and Oxone® have
the ability to be toxic to aquatic life. Moreover, there is limited information within literature
about the toxicity of these oxidizing agents to non-target organisms such as the microcrustacean
Daphnia magna (D. magna). The purpose of this study was to evaluate the acute toxicity of
KMnO4 and Oxone® to D. magna. The focus for this work is to determine the toxic effects on
non-target organisms using the U.S. EPA approved Whole Effluent Toxicity (WET) Test
performed with D. magna. Controlled Release Biodegradable Polymers (CRBP) were produced
by encapsulating KMnO4 and Oxone® in polycaprolactone (PCL) per U.S. Patent #8,519,061.
The CRBPs have previously been shown to be effective at reducing bacteria levels for
Escherichia coli (E. coli), Enterococci, and total coliform in contaminated water. It was
hypothesized that the CRBP could be a potential treatment technology to treat natural surface
waters without toxicity to aquatic life. The CRBPs were tested at 0.1g KMnO4 encapsulated in
0.5g PCL and 0.3g Oxone® encapsulated in 0.5g PCL and released for 24h, 48h and 72h in 1001000ml of natural surface test water to determine the toxic effects to D. magna. The results
showed that the WET Test using D. magna demonstrated Oxone® CRBP can cause severe toxic
effects to non-target organisms when released at any length of time, hence indicating potential
damaging effects on higher level aquatic life that may receive effluents treated with this strong
oxidant. Further results show that the KMnO4 CRBP caused minimal acute toxic effect in D.
magna when released at longer lengths of time. These findings show KMnO4 CRBP exhibit
promising minimal toxic effects on non-target organisms during environmental remediation.
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CHAPTER 1
Introduction
1.1 Background and Theory
Worldwide, waterborne diseases caused by impaired waters kill more people annually
than all forms of violence, including war. Waterborne diseases cause approximately 3.1 percent
of all deaths and 3.7 percent of disability adjusted life years worldwide (Ross, 2010). These
numbers suggest the importance of having access to safe drinking water and environmentally
friendly water for wild and aquatic life and the significance of reducing bacteria levels that can
cause sickness and death to humans, animals, aquatic life, and ecological environments.
Additionally, in the USA, it has been estimated that each year 560,000 people suffer from severe
microbial waterborne diseases, and 7.1 million suffer from mild to moderate infections, resulting
in an estimated 12,000 deaths a year caused by waterborne diseases such as Cholera,
Gastroenteritis and other serious salmonellosis bacterial diseases transmitted through water
(Cabral, 2010). Exploring remediation approaches could beneficially impact the rate at which
humans and non-targeted organisms will be affected. Adopting more advanced practices will
promote ecological processes and the treatment of natural surface waters and wastewaters.
The U.S. Environmental Protection Agency (EPA) provides a summary of water quality
assessment of each water body type, consisting of data that is reported in the National Summary
of State Information (NSSI, 2014). In 2008-2009, the EPA conducted the National Rivers and
Streams Assessment (NRSA), which provides information on the ecological condition of the
nation’s rivers and streams and the key stressors that affect them. In this report, the EPA states
that, in addition to overland flow:
Rivers and streams shape our landscape. They supply humans with drinking water, carry
away our wastes and used water, irrigate our crops, power our cities with
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hydroelectricity, and offer us myriad recreational and commercial opportunities. They
support fish and other aquatic life and provide shelter, food, and habitat for birds and
wildlife of all types. They are the land’s vast and interconnected circulatory system,
carrying water, sediment, and organic material from the mountains to the sea. Clean and
healthy rivers and streams greatly enhance the quality of our lives. (EPA, 2013)
According to the EPA, the number one cause of impairment in the nation’s rivers and streams is
pathogens. Out of 980,878 miles of rivers and streams assessed, 517,877 miles were reported to
be impaired. These impairments include bacteria such as Escherichia coli (E. coli), Enterococci
and Total Coliform and other chemical toxins such as nitrogen, mercury and phosphorous. The
majority of these impairments are found throughout the nation’s rivers, streams, lakes, ponds and
other forms of natural surface waters (US EPA, 2014).
1.2 Bacteria and Pathogens Found in Water
To help ensure bacteria and pathogens pose minimum to no risk from waterborne
diseases, standards and other measures set forth by the EPA are entrenched in practices to protect
human health and aquatic life in our nation’s surface waters (EPA, 2012). Although these
practices and other standards are in place, it remains evident that E. coli, Enterococci, and other
pathogens such as Cryptosporidium and Legionella bacteria (Cabral, 2010) continue to reside in
various areas of our waters even after chemical, biological or radiological treatment methods are
applied. According to Fricker (2003), natural waters contain a myriad of bacterial species. These
species for example Vibrio species, are a primarily aquatic bacteria that can infect humans
(Cabral, 2010). Vibrios are very common in estuarine environments and are also found in
freshwater habitats (Cabral, 2010) in which V. cholera is by far the most important of these
species. Cabral (2010) states that V. alginolyticus has been isolated from several types of soft
tissue infections occurring in human clinical specimens. The number of organisms present varies
considerably between different water types, and it is generally accepted that sewage-polluted
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surface waters contain greater numbers of bacteria than do unpolluted waters (Fricker, 2003).
Wastewater discharges in fresh waters are the major source of bacteria, including pathogens
(Cabral, 2010).
In 2013, the EPA provided the first statistically based survey of the nation’s rivers and
streams. This report, known as the National Rivers and Streams Assessment (NRSA): A
Collaborative Survey, assessed pathogens including chemical pollutants such as phosphorous,
nitrogen, mercury, and other harmful toxins that could pose relative risks resulting in degraded
biological and recreational conditions (EPA, 2013). The EPA in the NRSA Report indicated that
“phosphorus, nitrogen, and streambed sediments in particular have widespread and severe
impacts; reducing levels of these constituents will significantly improve the biological health of
rivers and streams.” (NRSA, 2013, p. 11). The findings of the report showed that 55% of the
nation’s rivers and streams are in poor condition and do not support healthy populations of
aquatic life due to widespread pollution impairments (EPA, 2013), and therefore, necessitates
improvement for the physical, social and environmental well-being of our society. In addition,
the EPA’s NRSA survey noted that more than half of the nations river’s and streams “exhibit
poor conditions” (NRSA, p.11).
1.3 Geographical Range of Pollution
Out of the three major climate regions assessed: 1) Eastern Highlands, 2) Plains and
Lowlands, and 3) the West, the East Highlands is reported to be in the worst biological condition
(NRSA, 2013, pp. 11-12). In this region, 62.7% of its rivers and streams impaired with high
levels of mercury, phosphorous and other chemical toxins that pose human health risks (NRSA,
2014, p.13). Sources of these pollutants include runoff from agriculture farms, urban activities,
industry, acid rain and airborne pollutants generated by human activities (Carpenter & Caraco,
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1998). In aquatic ecosystems, over enrichment with phosphorous and nitrogen causes a wide
range of problems, including toxic algal blooms, loss of oxygen, fish kills, loss of seagrass beds
and other aquatic vegetation (Carpenter & Caraco, 1998). These contaminants can also be a
stressor such as on physical habitats of wildlife, fish, and aquatic organisms. According to the
2008-2009 National Rivers and Streams Assessment conducted by the EPA, levels of mercury
have reached and exceeded 13,144 miles of the nation’s rivers and have exceeded the
Enterococci bacteria threshold levels established by the EPA to protect human health (p. 13).
Figure 1 depicts three climatic regions corresponding to major climate and landform patterns (the
West, Plains and Lowlands, and Eastern Highlands) that are used to report NRSA results.

Figure 1.1 Major National Rivers and Stream Assessment, 2008-2009 climate regions.
The National Summary of States Information has also assessed the nation’s lakes,
reservoirs, and ponds. Out of a total of 17,908,520 acres assessed, 12,117,213 acres were found
to be impaired (NRSA, 2014). The EPA and states are grappling with new and more stringent
water quality standards and parameters for different forms of contaminants found in our waters
due to these alarming numbers. These lakes are widely used for swimming, boating, and other
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recreational activities, but numerous microbial organisms, toxins and other contaminants cause
their impairment, which in turn can affect human health. These findings suggest the need to
address the many sources of these contaminants, including runoff from urban areas, agricultural
practices, and wastewater. Controlling the quality of runoff would ensure healthier waters for
future generations. Such a study may also find a cost effective way to treat impaired waters
(EPA, 2013).
Due to the increased number of polluted waters within the United States, feasible
solutions must be explored to address urban runoff, agricultural waste, and wastewater streaming
from sewage or industry in order to prevent human health and environmental exposures for
present and future generations (EPA, 2013). Efforts to address these concerns date back to the
1972 Clean Water Act, which implemented quality standards and established protection of the
beneficial uses of water such as swimming, maintaining fish and other aquatic life, and providing
drinking water for people, livestock and wildlife (EPA, 2013). Although the Clean Water Act of
1972 resulted in many successes in reforming practices and standards to address the harm that
generations of population growth and industrial development has inflicted upon the nation’s
waterways, further advances in water quality improvements are imperative. This is evident in
statements made in a congressional testimony comprised of challenges facing the EPA that
“bears on its ability to effectively manage, oversee, and enforce environmental laws, including
the Clean Water Act.”(Najjum, 2009) Most importantly, more efforts should be focused on
advancements in research and technologies that will aid significantly in countless water quality
improvements with additional improved cost-effective technologies. Innovative technology
partnerships to emphasize the treatment of centralized and distribution systems, urban runoff,
and nonpoint source pollution prevention should be encouraged.
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1.4 Controlled Release Biodegradable Polymers (CRBP)
Controlled release biodegradable polymers containing chemical oxidants are a novel
treatment method for wastewater (Luster-Teasley et al., 2009). For this method, oxidants are
slowly deposited into impaired water systems as a form of treatment. The benefit of using a
controlled release biodegradable polymer for natural surface water and wastewater treatment
consists of its ability to be placed at the site of contamination and directly treat the specific area
for an extended period. Another benefit to using a controlled release polymer for treatment is that
these chemicals are able to degrade into the environment and are constructed for specific need.
1.5 Thesis Scope
Chemical oxidants are typically used in gaseous and liquid form to treat groundwater and
soils contaminated with high levels of chemicals. North Carolina A&T State University was
recently awarded United States Patent No. 8,519,061 for a controlled release chemical oxidation
polymer system to remediate wastewater. This "environmental pill" is able to slowly release
either KMnO4 or Oxone® at controlled rates. The biodegradable polymer in conjunction with the
oxidants is effective in reducing bacteria concentrations in wastewater and the improvement of
color and odor for extended periods of time. This new technology can potentially be a method to
control the release of oxidants and thus reduce environmental, health and safety risks to the
public by improving public access to one of society’s most valuable resources -- clean and
bacteria-free water.
This thesis research will evaluate the toxicity of water treated with two chemical
oxidants, KMnO4 and Oxone®, using the EPA Whole Effluent Toxicity (WET) Test using
daphnia magna. The goal for this research is to determine the effective concentration levels and
potential environmental toxicity: (1) if contaminated wastewater is treated with the oxidants and
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returned to natural waters containing aquatic life and (2) if the technology is used for in-situ
treatment of impaired lakes, rivers, and streams containing aquatic life. This work will provide
guidance for the safe handling of this form of reclaimed wastewater. It will answer questions as
to whether treated wastewater must be reused on the property or if treated water can be returned
directly to surrounding natural waterways. This study therefore is key to understanding the
potential and the limitations for reuse of the treated wastewater. Previous studies (Taylor, 2012),
have indicated that the oxidant treated wastewater can be used for irrigation with little to no
impact to plant-life; however, the question remains for the impact or toxicity to aquatic life and
to determine the toxicity of the CRBP to aquatic life if the polymer is used in a natural system
(i.e. surface water at a park).
The order for the thesis is as follows: Chapter 2 will summarize the literature addressing
relevant information necessary to understand water contamination consisting of different types
and levels of bacteria, the reduction of bacteria with technological treatment methods, and the
significance of EPA’s Whole Effluent Toxicity (WET) Testing. Chapter 3 will present the
materials and methods consisting of detailed steps taken to conduct experimental objectives and
designs. Chapter 4 provides the findings and results from the study, including the best forms of
surface water and wastewater treatment; and finally, Chapter 5 will provide recommendations for
future studies.
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CHAPTER 2
Literature Review
2.1 Introduction
This thesis research involves evaluating the treatment of wastewater and natural water
(i.e. streams, rivers, ponds, and lakes) with the use of the chemical oxidants, KMnO4 and
Oxone®. KMnO4 and Oxone® are oxidizing agents, which are encapsulated in PCL, providing a
controlled release (CR) drug delivery agent. The controlled released biodegradable polymer
(CRBP) is hypothesized to treat both wastewater and natural water treatment systems in which
aquatic organisms may or may not exist. Wastewater will have little to no higher level aquatic
life; however, natural water that is impaired with fecal bacteria may have an assortment of
aquatic life living within the water.
Therefore, the goal for this work is to assess the potential toxicity of the CR oxidants if
released into impaired waters containing aquatic organism. D. magna will represent a freshwater
non-target organism to aid in determining alternatives to delay the progression of contamination
and increase avoidance to bacteria invading wastewaters and natural waters, in addition to aiding
in the reduction of bacteria exposed aquaculture environments. These experiments are carried out
in toxicity testing conditions and will be compared and contrasted against other related works.
Many experimental studies have been made on the influence of different chemical substances on
the toxicity of aquatic organisms. Only a few publications have assessed a standard toxicity test
on the acute toxicity associated with the use of KMnO4 and Oxone® to non-targeted organisms
such as D. magna. This literature review will review the background for water contamination
with fecal bacteria, chemical oxidants, and the CRBP technology-including a discussion about
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the polymer used, oxidants selected for bacteria treatment, and potential toxicity of the CRBP
system.
2.2 Bacteria
According to literature, pollutants have contaminated many of the nation’s rivers and
lakes. Industrial plants and municipal sewage treatment plants directly discharge some of these
pollutants while others come from polluted runoff in urban and agricultural areas, and some are
the result of historical contamination (Keyser, 1997). Importantly, bacteria and pathogen
contamination are a growing concern due to large temporal and spatial variations in
concentrations and diverse sources of bacteria in our nations waters (He, Lu, & Shi, 2007). The
Centers for Disease Control (CDC) has identified bacteria and pathogen water contamination as
major causes of water related outbreaks, triggering gastrointestinal illnesses such as: diarrhea,
nausea, stomachaches, and vomiting. These microbial yields often impact recreational water use,
hence making areas undesirable for swimming or fishing, while killing natural aquatic organisms
in these ecosystems. There are numerous types of bacteria that contribute to the contamination
of water and the spread of disease. Some of these microorganisms include coliform bacteria.
Coliforms enter water supplies from the direct disposal of waste into streams or lakes, or from
runoff from wooded areas, pastures, feedlots, septic tanks, or sewage plants into streams (Keyser,
1997; Baxter-Potter & Gilliland, 1998).
Coliforms will be one of the first bacteria present in the water should contamination
occur, and they will be in much larger quantities than some pathogenic microbes that may be
present. Therefore, coliforms act as indicators of possible contamination (Keyser, 1997). E. coli,
and Enterococci. Classified as fecal bacterial indicators, these microorganism groups allow for
the detection of possible waterborne illnesses. Total coliform is rod-shaped bacteria, which
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include a related group of bacterial species including: E. coli, Enterobacter, Klebsiella, and
Citrobacter. Enterococci are gram-positive bacteria commonly found in the feces of warmblooded animals, including humans. The cell membrane is comprised of peptidoglycan layers
that form a thick outer shell and is more resistant to remedial treatment than E. coli, and Total
Coliform (Rogers, 2012). Enterococci bacteria are used to indicate water contamination by fecal
waste and are also used to evaluate recreational water quality and health risks in aquatic
environments. Sustainable eco-friendly methods to efficiently treat contaminated water systems
while also help mitigate these ongoing wastewater issues must be developed.
Over many years of research, recreational water quality has been assessed by using
various water quality bacterial indicators such as Total Coliform, fecal coliform (E. coli), and/or
Enterococci. The Clean Water Act of 1970 requires that a Total Maximum Daily Load (TMDL)
is measured and tracked for bacteria impaired water bodies. He et al. (2007) suggests that the
development and implementation of bacterial TMDLs has prove challenging due to unknown
sources of indicator bacteria. According to a study done by He, Lu et al. (2007), they found that
bacteria indicator levels in pond water were significantly higher than bacteria levels in flowing
waters, hence resulting in pond water sediments containing a greater amount of indicator
bacteria. Therefore, point sources (i.e. municipal wastewater treatment plants, sewage spills and
permitted discharges) and nonpoint sources (i.e. agricultural runoff, animal waste, human waste,
commercial and residential storm water runoff) pollution contribute to the bacterial numbers in
water bodies (Carpenter & Caraco, 1998). It is important to consider practical and applicable
treatment methods, while developing and implementing strategies to reduce their numbers in
recreational water bacteria and pathogen-impaired water bodies.
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2.3 Chemicals and Oxidation
Chemical oxidants, or Advanced Oxidation Technologies, are effective chemical
oxidations processes G. Anipsitakis and Dionysios (2003) that allow for this occurrence.
Chemical oxidation is a process that modifies the structure of pollutants through the addition of
an oxidizing agent. During oxidation, one or more electrons transfer from the oxidant to the
targeted pollutant that is further destroyed. Chemical oxidants provide an innovative and highly
cost effective method for treating contaminated waters and are beneficial for remediating a wide
variety of chemical and biological contaminates.
Chemical oxidants are highly reactive, non-selective chemicals that generate hydroxyl
radicals that are able to degrade environmental contaminants (S. Luster-Teasley, Shah, Onochie,
& Shirley, 2010). The oxidation process has proven effective for rapid treatment of many waste
water issues, and is currently being used for application at large industrial and municipal
treatment facilities across the U.S. Certain studies where oxidants are being coupled with
transition metals used to treat hazardous substances in water show the potential of oxidizing
agents to readily attack and degrade both organic and microbial contamination in water (G. P.
Anipsitakis, 2005). A study by Doan et al. (2013) expressed that chemical oxidation was applied
to treat contaminated sediments, where results showed a 2-log decrease in the number of 16S
rRNA gene of total bacteria in the sediment having the lowest organic matter content.
Contaminant degradation rates were monitored in other studies. The contaminant concentrations
were significantly reduced by a polymer- chemical oxidant combination without inhibition of
degradation rates (Smith, Silva, Munakata-Marr, & McCray, 2008).

14
2.4 Polycaprolactone
Polycaprolactone (PCL) is a semi-crystalline polymer that is biodegraded by living
organisms (Woodruff & Hutmacher, 2010). Due to its biodegradable properties, PCL has been
used as a controlled release polymer for drug delivery applications, and has been estimated to
have total degradation from 2-4 years (Woodruff & Hutmacher, 2010; Taylor, 2012). The article
by Woodruff and Hutmacher (2010) noted that PCL has a very low melting point and a transition
glass temperature of around 60°C with exceptional blend capabilities. Tucker and Johnson
(2004) carried out an investigation of PCL and other blends, finding after 20 days of incubation
PCL composites were almost completely biodegraded at 60% degradation. When used as a
controlled release, PCL’s characteristics make it beneficial including low melting point and
blend capabilities, controlled degradation kinetics, as well as easy formability through physical
manipulation for shaping purposes. This distinguishes PCL as one of the most attractive and
versatile biodegradable plastics (Chien & Yang, 2013). Figure 2.2 shows the molecular formula
of PCL, which includes five non-polar methylene groups and a polar ester group.

Figure 2.1 Polycaprolactone (PCL)
A research study investigating the effectiveness of progesterone encapsulated in PCL as a
controlled release drug delivery agent was investigated by Salmoria et al. (2009). Progesterone is
a steroid hormone that is used for endometrial cancer treatments, and as contraception control.
Controlled release polymers use similar controlled release drug delivery technology to release
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oxidants to disinfect and treat water systems. According to Puoci (2008), polymer delivery
systems have helped the agriculture industry combat viruses and other crop pathogens, allowing
lower doses to be used and to protect the environment to reduce pollution and cleanup existing
pollutants. Additional advantages to using PCL is its bulk degradation capability with no residual
side effects due to PCL’s half-life being twenty days. This allows the polymer to diffuse over
time without affecting the molecular weight of the internal bulk of the polymer, which generally
continues to remain unchanged over the degradation period (Woodruff & Hutmacher, 2010).
Bulk degradation transpires when water penetrates the entire polymer, causing hydrolysis
throughout the entire structure, which makes it suitable for water treatment purposes (Woodruff
& Hutmacher, 2010). Another advantage includes PCL’s predictability, giving desirable release
rates, which can be predetermined. Rogers (2012) found this to be true when investigating the
release rates of polymer blends developed in Dr. Stephanie Luster-Teasley’s research group
using oxidants. This led to discovering a predetermined release rate of oxidizing agents being
released from a polymer composited structure. Additionally, PCL can easily be manufactured
and manipulated into a large range of shapes and sizes. It is also relatively inexpensive for
production and is FDA approved.
2.5 Potassium Permanganate
Potassium permanganate (KMnO4) is made up of dark purple odorless crystals, and is
soluble in water-chlorinated solvents with by-products of its use being environmentally harmless.
It can be used as an oxidizing agent, bleach or dye (Kang, Hua, & Rao, 2004). KMnO4 can be
used to control taste, odor, and to control biological growth in treatment plants. It is also widely
used in aquaculture for the control and removal of parasites and in the prevention of diseases
caused by bacteria and fungi (Franca, 2011). KMnO4 solution is often added to the raw water
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intake, in conjunction with coagulants, or in clarifiers in water treatment plants. It has been
shown to inactivate certain organisms such as E. coli and poliovirus (US Environmental
Protection Agency, 2012). This strong oxidant is easy to handle, is a readily soluble solid, and
has a high efficiency in treating water and soil with a cost of $2.25 per pound for 98% material
(2014 cost), depending on the quantity ordered. Figure 2.2 depicts the chemical structure of
KMnO4. As of 2006 KMnO4 was not approved by the U.S. Food and Drug Administration as an
aquaculture therapeutant (Hobbs, Grippo et al. 2006).

Figure 2.2 Potassium Permanganate
Hobbs, Grippo, Farris, Griffin, and Harding (2006) evaluated the acute toxicity of
KMnO4 to non-target aquatic organisms to assess its exposure to aquatic life using acute toxicity
testing. Previous research on the therapeutic use of KMnO4 as a disinfectant has not taken into
account any toxicity to nontarget aquatic organisms. The toxicology, methodology, and
evaluations used by Hobbs et al. (2006) contributes significantly to the evaluations of the
controlled release chemical oxidant system for wastewater and natural water treatment in
addition to chemical oxidant toxicity to D. magna and higher aquatic species. Hobbs et al.
(2006) conducted a static 96-h acute toxicity test where four non-target aquatic species of
invertebrates and one species of fish (Ceriodaphnia dubio, Daphnia magna, Pimephales
promelas, Hyalella Azteca, and Chironomus) were cultured and tested to evaluate the
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environmental risks KMnO4 exposures has on non-target organisms. The test species used in this
study represent a range of organisms that are typically found in freshwater ecosystems such as
ponds. Test organisms were cultured according to standard U.S. Environmental Protection
Agency procedures and survival data were recorded every 24-h.
Four replicates were used per six treatments for each test ran in triplicate. All tests were
conducted under a 16:8-h light:dark photoperiod and organisms were not fed during exposures.
Two different types of water were used during this study using both moderately hard synthetic
water and pond water. To determine whether pond water would have an ameliatory effect on
KMnO4 toxicity, pond water was used. Water samples were collected and stock solutions were
prepared using either water type, and serial dilutions were then made for the correlated exposure
treatments at the nominal concentrations. Control test waters contained no KMnO4. Test
solutions and then the organisms were added to the experimental chambers of test solution.
Values for survival from toxicity were then collected and analyzed. This research study was
necessary because there was limited data concerning KMnO4’s toxicity to non-target organisms
in an aquaculture environment.
Results of this study showed the majority of mortality occurred during the initial 48-h of
the 96-h testing period. Hobbs et al. (2006) found that two species of Cladocerans, D. magna
and C. dubia were the most sensitive to aqueous KMnO4 for both synthetic and pond water
exposures. Mean lethal concentration (LC50) values and standard deviation of 0.053 ± 0.009 mg
L-1 for D. magna was found in hard water, and 1.98 ± 0.12 mg/L for the pond water was
detected after the 96-h toxicity test. The value of D. magna’s LC50 was below the recommended
KMnO4 treatment rate of at least 2.0 mg/L or 2.5 times the 15-minute water’s potassium
permanganate demand (PPD). The PPD is the measure of the amount of organic matter and other
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reducing agents present in the water. The PPD of the synthetic moderately hard water was 0.329
± 0.114 mg/L and for pond water the PPD was 5.357 ± 0.967 mg/L. Although pond water offers
an ameliorating effect on KMnO4, in order for the treatment to be effective, 2.5 times the PPD
would have to be 0.823 and 13.392 mg/L KMnO4, respectively, which would exceed the LC50
for most non-target organisms after treatment and showing that water column invertebrate
herbivores are likely to be affected first. This may be due to KMnO4 ability to dissociate to the
permanganate ion (MnO4-) once introduced to an aquatic system, a strong oxidizing agent, which
is likely the reason for the rapid toxic effects. Ultimately, Hobbs et al. (2006) concluded that the
test result from their study does represent an initial investigation into the possible effect that
KMnO4 treatments may have on non-target aquatic organisms.
More recently, few studies have evaluated the toxicity of KMnO4 to higher-level aquatic
organisms. Darwish, Griffin, Straus, and Mitchell (2002) conducted a histological and
hematological study on channel catfish Ictalurus punctatus to evluate the effect of KMnO4
exposure. Three concentrations of KMnO4 were chosen to represent one, three, and five times
the therapeutic concentrations (0.438, 1.315, and 2.190 mg/L, respectively), based on the
KMnO4 demand, for 36-h. and discovered no mortalities in fish not exposed (control) or in fish
exposed to the therapeutic dose of KMnO4. Mortalities were only observed in fish exposed to
three and five times the therapeutic dose of KMnO4 (9.4% and 49.6%, respectively) with most of
these mortalities occurring from exposure to 2-d postexposure. The result of these studies have
shown that higher aquatic organisms’s exposure to KMnO4 produces minimal signs of stress
when exposure is within the suggested therapeutic concentrations range. Cruz and Tamse (1986),
Darwish et al. (2002), Griffin, Gollon, Hobbs, Kadlubar, and Brand (1999), and Griffin, Davis,
Darwish, and Straus (2002) have shown that sublethal changes appear to be temporary and that
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fish recover when returned to a KMnO4 free environment, implying that KMnO4 used as a
waterborne disease therapeutant for channel catfish does not alter manganese content of edible
muscle of channel catfish and should not present any hazard to human consumers. Furthermore,
no changes were observed in any stress indicators measured suggesting that KMnO4 may be
safely used as a disease therapeutant for channel catfish and other higher aquatic organisms.
Zahran and Risha (2013) have also discovered that KMnO4 has proven to be a beneficial effect
against certain fish diseases such as saprolegniosis and show a protective role against
oxidative damage in saprolegniosis-infected Nile tilapia. Allowing water to break down further
may be the next steps to observe D. magna’s mortality effects by using [A] – [A0] = -K* t; where
the K value is the release of 0.0011g per day for KMnO4 treatment (Roger, 2012).
2.6 Potassium Peroxymonosulfate
Potassium peroxymonosulfate (KHS05 or Oxone®), a strong and highly water-soluble
oxidant, is purposed with high oxidation potential and can be used in various particle treatment
water applications (G. P. Anipsitakis, Tufano, & Dionysiou, 2008). Oxone® is a commercially
patented chemical that is available through DuPont™. Oxone® provides powerful non-chlorine
oxidation for a wide variety of industrial and consumer uses such as waste streams from mining
operations and as a non-chlorine shock oxidizer for swimming pools and spas. Oxone® can also
be used as an oxygen releasing agent in aquaculture and as a low temperature bleaching agent in
detergent formulations (Sánchez-Fortún, Llorente, & Castaño, 2008).
One of the major drawbacks of Oxone® treatment is the potential for ecological impacts
following Oxone® release into receiving waters. The outcome of this occurrence results in acute
toxicity from high concentrations of Oxone®, likely impacting river and lake areas. Due to
Oxone® chemical characteristics, it is expected to dissociate into potassium (K+) and
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peroxymonosulfate (SO5-) ions if released in natural waters (Sánchez-Fortún et al., 2008).
Furthermore, the U.S. EPA has noted that peroxy compounds are known to be short-lived, with
Oxone® half-life of 910 days (Durante & Bohn, 2007) due to their instability of the O-O bonds
and are expected to degrade rapidly, Figure 2.2 (U. S. EPA, 1993).

Figure 2.3 Potassium Peroxymonosulfate (Oxone®)
Kennedy and Stock (1960) were among the first to investigate the reactions of a stable
mixture of Oxone® with a variety of organic substances, as well as the utility of Oxone® in
halogenation reactions. Rachlin & Perlmutter, 1968 were the first to suggest the in vitro use of
fish cells for the assessment of the toxicity of environmental pollutants to aquatic biota.
Observing the interactions between chemical contamination and biological systems with the use
of in vitro cell cultures for ecotoxicological assessments can therefore be a valuable tool for an
early and sensitive detection of chemical exposure (Sánchez-Fortún et al., 2008). Sanchez-Fortun
et. al. (2008) used cytotoxicity testing to evaluate the toxic effects of Oxone® to determine if the
compound would exhibit a risk to fish and other aquatic organisms after hull cleaning activities,
leading to particles containing Oxone® entering the aquatic environment. The goal of that study
was to also determine the effect of DNA damage induced by Oxone® used as an disinfectant in
cooling towers, in RTG-2 cell line (Sánchez-Fortún et al., 2008).
Cell lines have been used extensively to study the cytotoxicity of substances to fish cells
(Bols, Dayeh, Lee, & Schirmer, 2005). Using a RTG-2 cell line, derived from rainbow trout
gonadal tissue, two types of toxicity assays where performed. These two assays consisted of a
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Neutral Red Assay and a DNA Denaturation Assay. The Neutral Red Assay included rainbow
trout gonadal tissue cells that were seeded into a tissue culture plate. After a cell incubation
period, cells were then incubated with Oxone® followed by replacement with neutral red
solution. DNA denaturation assay included a 48-h cytotoxicity test performed to determine the
desired range of concentration of Oxone® that resulted in loss of cell viability. DNA denaturation
kinetics was performed with different serial dilutions of Oxone® with concentrations ranging
from 5-500 mg/L, and double-stranded DNA percentages were calculated in relation to control;
comparisons of untreated (control) and treated cells was then performed.
Sanchez-Fortun et. al. (2008) found that the RTG-2 cell from rainbow trout gonadal
tissue is sensitive to Oxone® chemical exposure, which has the ability to incur DNA denaturation
and break DNA strands. However, no significant differences with respect to control were
obtained when RTG-2 cell were exposed to Oxone® concentrations, obtaining a maximal strand
scission factor (SSF) of 0.070. The median inhibition concentration (IC50) for Oxone® was
101.11 mg/L and yield 95% confidence limit values 79.59 mg/L – 137.05 mg/L. Following
exposure to Oxone®, induction of DNA damage concluded that after 30 min, less than 20% of
DNA from control wells were denatured. Detecting small valued amounts of DNA is extremely
important in a wide variety of biological applications. In further studies using established cell
lines derived from bluegill sunfish (BF-2), rainbow trout gonads (RTG-2), and steelhead trout
(STE), Castaño et al. (2003) evaluated the cytotoxicity of similar substances (Sánchez-Fortún et
al., 2008), finding that higher aquatic organisms are affect by exposure.
2.7 Controlled Release Biodegradable Polymer (CRBP)
Using biodegradable polymers to deliver chemical oxidants for agricultural and
biomedical purposes have been proven effective (Akelah, 1996; Al-Zahrani, 1999). Akelah
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(1996) shows that delivery of herbicides to plants at a controlled rate and in appropriate doses
over a specified time has the ability to overcome serious environmental problems conventional
herbicides present. In other works by Uhrich, Cannizzaro, Langer, and Shakesheff (1999) has
determined that controlled release systems can be a carrier for drugs; improving efficiency,
reducing toxicity, and improving patient compliance and convenience within delivery
applications and in cases of placing non-toxic implants under the skin of humans. Notably, the
CRBP is a solid at room temperature, soluble in water, chemically compatible with the oxidant
of choice, and environmentally friendly (Kang et al., 2004).
However, current literature shows that CRBP systems used for environmental purposes
such as environmental protection, decontamination, and remediation continues to be a
developing area within the body of environmental engineering. This facilitates the need to utilize
CRBP to resolve environmental remediation and treatment of diseased water issues. There are
several advantages to using a CRBP to treat contaminated water systems. Within this type of
method, the oxidant remains stable when placed in a treatment system, it has the ability to reduce
the amount of times infected waters may need treatment and it extends the release of the oxidant
over a particular span of time. Figure 2.4 depicts the oxidant and polymer blend release system
for oxidant discharge into water systems. First, the soluble polymer is placed in water and small
pores are formed. The oxidant molecules then begin to diffuse with the water and disperse into
the environment. Lastly, the oxidant is released and the polymer shell degrades naturally over
time (S. Luster-Teasley et al., 2010).
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Figure 2.4 Controlled release polymer design (S. Luster-Teasley et al., 2010)
Following careful literature analysis and experimentation, S. Luster-Teasley et al. (2010),
Luster-Teasley et al. (2009) and Rogers (2012 ) shows successfully developed encapsulated
oxidants to create controlled release systems for remediation, in particular utilizing the chemical
oxidants KMnO4 and Oxone®. KMnO4 and Oxone® were encapsulated inside the CRBP. The
release of these oxidants in deionized water was then studied. In addition to release studies, the
ability of Oxone® to treat contaminated water was also studied (Rogers, 2012). To prove this
development was successful, stable, non-reactive and sustainable for extended longevity,
KMnO4 was encapsulated and mounted on a glass slide. Photos at 40x and 100x were then taken
of the CRBP using a digital microscope to observe any of these reactions along with signs of
shell discoloration (Luster-Teasley et al., 2009). Figure 2.5 shows stable and non-reactive
KMnO4 encapsulated in the CRBP. Figure 2.5a is a photo of the KMnO4 in the CRBP shell
photographed on May 16, 2006 and Figure 2.5b shows the same sample on December 12, 2006
(Luster-Teasley et al., 2009).
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(a)

(b)

Figure 2.5 Photo of CRBP with KMnO4: (a) CRBP with oxidant at month zero and (b) CRBP
with oxidant at month seven (Luster-Teasley et al., 2009).
2.8 Toxicity of Controlled Release Biodegradable Polymer
Biodegradable materials are natural or synthetic in origin and are degraded to produce
biocompatible and toxicologically safe by-products (Makadia & Siegel, 2011). The area of
environmental remediation is a continuous emerging area targeting controlled release uses
known to lower toxicity of the CRBP and decrease risks associated with treatment. Makadia and
Siegel (2011) found that some pellet fabrication systems are also open to the risk of denaturation
of drugs during encapsulation.
However, Rogers (2012) investigated this area and developed the appropriate procedure
for a particular CRBP fabrication to lower the toxicity of the system and merit reasonability that
toxicity remains low and environmental remediation remains highly effective. Rogers (2012)
also investigated to the release rates of the CRBP developed in the Dr. Stephanie Luster-Teasley
research group using the oxidants KMnO4 and Oxone® encapsulated within the CRBP shell.
Through this study, Rogers (2012) determined a release rate of 0.0013 g per day over a 65 day
period that was recorded for 0.1g KMnO4 encapsulated in 0.5g polymer. Also discovered was a
release rate of 0.011 g per day over a 19 day period that was recorded for 0.3g Oxone®
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encapsulated in 0.5g polymer. These findings provide valuable information to construct the ideal
CRBP system to reduce toxicity and increase the amount of treatable water systems.
Previous literature including (Craig, 2010), Rogers (2012), S. Luster-Teasley, Jackson,
and Rogers (2011), Foster (2012), and McLeary (2013) investigated the production and use of
the CRBP to treat natural surface water and wastewater from confined animal feeding operations
(CAFOs). It was found that the CRBP technology was successful at reducing bacteria levels such
as E. coli, Enterococci and Total Coliform and was also effective at treating for color and odor.
Additionally, Taylor (2012) investigated the toxicity of treated wastewater and natural water to
plants. Results showed that KMnO4 CRBP and Oxone® CRBP did not adversely effect Soy Bean
Plants or Grasses for plant growth, height or appearance. Tissue cultures from a human lung
carcinoma (A-549) cell line were also investigated to determine the toxicity of the CRBP and
results showed that KMnO4 CRBP and Oxone® CRBP did not adversely effect human tissue
cultures.
2.9 US EPA WET Test
According to the Clean Water Act Section 402, to maintain the chemical, physical and
biological integrity of the nation’s water, the Whole Effluent Toxicity (WET) test is a vital
component for improving water quality standards (U.S. EPA, 2000). The U.S. Environmental
Protection Agency has declared Daphnia Magna (D. magna) a marker to determine whether
diverse forms of chemical substances and mixture exposures are toxic to aquatic life within
aquatic environments. The WET test will measure an organism’s response such as lethality,
impaired growth, or reproduction upon exposure to the water sample. The WET test also enables
us to replicate the total effect and actual environmental exposure of aquatic life to toxic
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pollutants within wastewaters and natural waters without identifying the specific pollutants. This
can be considered as one of the initial indicators for toxic water (EPA 2000).
D. magna are primarily used for this type of bioassay because of their exceptionally
sensitive behavior to chemicals and stressors in water. D. magna is derive from the Phyllopoda
species, which is a form of freshwater crustacean that has been studied over the past 250 years
(Ebert, 2005). They are characterized by having leaf-like legs, and antennas which are used for
swimming in various habitats of lakes, ponds, rocky pools, and other forms of natural waters
found around the world. These locations include the northeastern U.S. Atlantic coastline, parts of
Western Europe, and the Netherlands.
D. magna are an important food source for fish and other bigger aquatic organisms. D.
magna, also known as Cladoceran freshwater flea, are very small crustaceans consisting of an
overall body shape of a kidney bean, bounded by a transparent shell-like structure, called a
carapace, whose body length ranges from less than 0.5 mm to 5mm in size. An adult D. magna
has the ability to release 4 to 10 eggs at a time within 38 hours. Although, it is not uncommon for
adults to produce up to 20 eggs at a given time. The growth rate of the organism will vary due to
many environmental factors such as temperature, pH, and food supply. Due to the transparency
of its carapace, this species tends to reflect the color of what it is currently eating, also allowing
for visible internal organs and easier recognition of organisms within culture. Males comprising
of smaller size and larger antennas can distinguish female and male D. magna. Figure 1 depicts
the physical description of D. magna. The fact that these organisms are able to live in algal
blooms, daphnia feed on algae and bacteria, where various studies show that they prefer algae as
food (Keating, Caffrey, & Dagbusan, 1996). The benefits to using D. magna for this type of
bioassay prove excellent organisms to test because they are extremely sensitive to changes in
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water chemistry and they are simple and inexpensive to nurture in an aquarium. They mature in a
matter of days, therefore, they do not take long to grow and become ready for testing.

Figure 2.6 Anatomy of D. magna
Therefore, in this thesis research, D. magna can be early indicators that there is a
potential contamination in water, hence reducing the negative impact if concentrations of the
chemical increase over time D. magna will aid in determining alternatives to delay the
progression of contamination and increase avoidance to bacteria invading natural waters in
addition to aiding in the reduction of bacteria exposed aquaculture environments. Using the
controlled released biodegradable polymer, experimentation will occur to observe the survival
and death in D. magna in different forms of impaired waters. This research is intended to serve
as support for environmental toxicology, wastewater resources and environmental communities
to provide data that can be used in determining the environmental impacts of KMnO4 and
potassium Oxone® exposures to non-target organisms.
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The purpose of this study was to evaluate the acute toxicity of KMnO4 and Oxone® to D.
magna. The focus for this work is to determine the toxic effects on non-target organisms using
the U.S. EPA approved Whole Effluent Toxicity (WET) Test performed with D. magna.
Controlled Release Biodegradable Polymers (CRBP) were produced by encapsulating KMnO4
and Oxone® in PCL per U.S. Patent #8,519,061. It was hypothesized that the CRBP could be a
potential treatment technology to treat natural surface waters without toxicity to aquatic life. The
research objectives for this study include:
1. Trial I:
(a) Toxicity of pure PCL to D. magna
(b) Toxicity of oxidants KMnO4 and Oxone® without encapsulation.
2. Trial 2: Toxicity of oxidant encapsulation; KMnO4 CRBP and Oxone® CRBP
3. Trial 3: a time-based experiment to see the toxicity of Oxone® CRBP to D. magna on
an hour-by-hour basis.
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CHAPTER 3
Methodology and Procedures
The experiments for this research were developed to investigate a controlled release
treatment that releases a chemical oxidant for an extended period of time. The goal was to
determine if this method could be directly applied to treat impaired water. Also to determine if
use of controlled release polymers as a delivery system for oxidants can provide effective
treatment at environmentally safe levels by exploring toxicological impacts, environmental
impacts, and determining safe treatment levels for KMnO4 Controlled Release Biodegradable
Polymers (CRBP) and Oxone® CRBP.
3.1 Experimental Design
D. magna (daphnia) used in this study were purchased from Carolina Biological Supply
Company (Burlington, NC) and cultured in tanks of spring water under the hood at 68 - 72°C.
The daphnia were fed Spriulina algae every 2 days or as needed. Acute toxicity tests were
conducted with D. magna. D. magna were tested according to U.S. Environmental Protection
Agency standards and procedures (US EPA, 2003). Data resulting in death, survival, and
reproduction were recorded every 24 h. Randomly selected adult and juvenile test organisms
from the stock daphnia tank were used for the experiments. Tests were conducted using bottled
spring water and natural pond water impaired by community run-off.
To investigate whether effluent water treated with the CRP systems containing either
KMnO4 and Oxone® would adversely affect daphnia used as an indicator organism for toxicity,
pond water was obtained from Country Park Lake located in Greensboro, N.C. and commercially
available spring water was used as the test water. Country Park Late water was collected by
using a telescopic environmental sampling pole shown in Figure 3.1. Water was then placed in
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wide mouth sampling bottles, transferred in a cooler and stored within a refrigerated environment
until use.

(A)

(B)

(C)

Figure 3.1 (A) Sampling pole (B) sampling dip container (C) sampling bottle
3.2 Controlled Release Biodegradable Polymer (CRBP) Formulation
The CRBP system is one of the focal points for all experiments performed in this study.
CRBP was produced using an encapsulation method from Rogers (2012) and a modified method
proposed in Kang et al. (2004). This thesis uses the same KMnO4 and Oxone® CRBP
formulation as used in Rogers (2012). For CRBP, 0.5g PCL + 0.1g KMnO4 (KMnO4 CRBP) and
0.5g of PCL + 0.3g Oxone® (Oxone® CRBP) was blended and used for treatment.
Table 3.1
Chemical Blends and Concentrations Tested
Chemical Blend

Mass of Chemical (g)

PCL

0.5

KMnO4

0.1

Oxone®

0.3

31
CRBP were made by heating PCL at 90°C on a hotplate. KMnO4 was added to the molten PCL
and mixed until completely blended together. Mixture was then removed from the hotplate. The
polymer and oxidant mix was allowed to cool briefly and was rolled into a long, round solid coil,
and cut into smaller pieces to achieve a pillow shaped pellet, shown in Figure 3.2. The
formulation was then stored in a dry area. This process was repeated to prepare CRBP consisting
of the Oxone®.

Figure 3.2 KMnO4 and Oxone® CRBP pellets
3.3 Stock Solution Preperation
Stock solutions were prepared by using between 100ml – 1000 L of either pond water or
spring water with either pure KMnO4 or Oxone®, polymer or, CRBP pellets added to the water.
Luster-Teasley et al. (2009) has shown that one batch of CRBP consiting of 0.3g Oxone® in 0.5g
PCL can effectively remediate 200 – 500 ml of wastewater. This information provides details
needed to understand the release portion of the CRBP over time that was used to remediate test
waters. Volumes of test waters ranging from 100 ml-1L of water were investigated for the
studies. The CRBP pellets were allowed to release in the water for 24 hours. After 24 hours, the
solution was then transferred into the experimental chambers. Figures 3.3 shows Country Park
water along with KMnO4 and Oxone® CRBPs in pellet form release in to prepare stock solutions.
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(A)

(B)

Figure 3.3 (A) KMnO4 CRBP release (B) Oxone® CRBP release
3.4 D. magna Culture Preparation for WET Test
According to the U.S. EPA, in order to determine the toxic effect of an environmental
treatment, a Whole Effluent Toxicity (WET) test can be conducted to measure an organism’s
response due to exposure (EPA, 2004). For this thesis, a static acute WET test was performed by
exposing D. magna to various treatments for a period ranging from 3 days to 12 days. This was
performed to assess the toxicity levels associated with the oxidants encapsulated in the CRBP
and treated wastewater. D. magna were allowed to grow for at least three weeks in the stock
daphnia tank before used for toxicity tests. This was to ensure that there would be a sufficient
amount of test organisms without a shortage and that adult daphnia were used. Figure 3.4 depicts
culture of D. magna in aquarium.

Figure 3.4 Culture of D. magna
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3.5 Acute Toxicity Test Procedure
For testing, 10 to 15 pill cups (experimental chambers) were used for each treatment.
Crystal Geyser Natural Alpine Spring Water and Country Park water was used for stock
solutions. Table 3.1 summarizes the solution concentrations, water type, and the length of each
test. In Table 3.1, CRBP treatment blends consist of a control, PCL only and combinations of
PCL with the selected polymer blend material that was placed in different volumes of water.
CRBP was left to release in the water from a minimum of 24 hours to a maximum of 72 hours.
After completion of time release, CRBP was removed from water to prevent further release.
Water was used for D. magna experimental chambers. Test organisms were then transferred to
chambers to begin testing.

Figure 3.5 Trial I Experimental Design
Treatments were labeled according to treatments and concentrations being tested and observed
for a specified duration of time. Results were recorded every 24 hours and organisms were fed
every other day. Statistical analysis was performed using GraphPad© Prism Software, Inc. Any
differences among treatments were analyzed by one-way Analysis of Variance (ANOVA), taking
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p<0.05 as significant. Bonferroni’s multiple comparison tests were used as a posttest to further
investigate significant values.
Table 3.2
Overview of Treatments and Concentrations for Trials I, II and III

Spring/CP

Test Volume
(ml)
100-1000

Test Duration
(d)
3-12

Time Release
(hr)
−

CP

100

3

24

Prep C: 0.5g PCL + 0.1g KMnO4

Spring/CP

100-1000

3-12

24-72

Prep D: 0.5g PCL + 0.3g Oxone®

Spring/CP

100-1000

3-12

24-72

Treatment
Prep A: Untreated Control
Prep B: 0.5g PCL

Water Type

*CP: Country Park Lake water
3.6 Trial I: Toxicity of PCL and Pure Oxidants to D. magna
D. magna were exposed to treated water to determine the toxicity of the CRBP.
Treatments consisted of PCL and oxidant blends. In Table 3.2, for this experiment 0.5g PCL in
pure form (no oxidant) was added directly to each pill cup. To begin this experiment a baseline
concentration had to be performed to determine if the chemicals in pure form were toxic. This
was a preliminary test to see if PCL polymer was toxic to D. magna and to see if oxidants
without encapsulation will have an effect on the organisms. The hypothesis for the preliminary
test was 0.5g PCL used for the CRBP would not be toxic to D. magna. Oxidants were added to
100ml of CP water (see Table 3.3 for concentrations) for stock solution and were allowed to
release for 24 hours. A pure CP water control was used. Forty pill cups in all were separated into
four groups of ten, one set of ten for Prep A, one set of ten for Prep B, etc. With a pipette, 10ml
of stock solution was added to each pill cup. Test organisms were then added. Treatments were
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labeled as shown in Table 3.3 and observed for 3 days. Results were recorded every 24 hours and
organisms were fed every other day.
Table 3.3
Labels for Trial I Treatments and Concentrations

Prep A: Untreated Control

CP

Test
Volume
(ml)
100

Prep B: 0.5g PCL

CP

100

3

24

*Prep C: 0.5g PCL + 0.1g KMnO4

CP

100

3

24

*Prep D: 0.5g PCL + 0.3gOxone®

CP

100

3

24

Treatment

Water
Type

Test
Duration
(d)
3

Time
Release
(hr)
−

*Oxidants (KMnO4 and Oxone®) were not encapsulated to see impact of the full concentration.
3.7 Trial II: Toxicity of Oxidant Encapsulation (CRBP) at Different Volumes and Release
Times
3.7.1 Toxicity of Oxone® CRBP in 300ml and 400ml. Testing D. magna toxicity
against Oxone® CRBP was performed in a series of experiments. The CRBP was formulated
according to procedures explained in section 3.2. Oxone® CRBP was added to 300ml and 400ml
of CP water for stock solution and was allowed to release for 24 hours. A pure CP water control
was used. This 24-hour period also allowed for the water to reach room temperature (approx.
20°C) after being refrigerated. Sixty pill cups in all were separated into four groups of fifteen,
two sets of fifteen for Prep A and two sets of fifteen for Prep B. With a pipette, 10ml of stock
solution was added to each pill cup. Test organisms were then added. Treatments were labeled as
shown in Table 3.4 and observed for 3 days. Results were recorded every 24 hours and
organisms were fed every other day.
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Table 3.4
Labels for Treatments and Concentrations Tested for Oxone® Toxicity
Treatment

Water
Type
CP

Test Volume
(ml)
300

Test Duration Release Time
(d)
(hr)
3
−

CP

400

3

−

CP

300

3

24

CP

400

3

24

Prep A: Untreated Control

Prep B: Oxone® CRBP

3.7.2 Toxicity of KMnO4 CRVP vs. Oxone® CRBP in 500ml. Testing to compare
KMnO4 CRBP and Oxone® CRBP was done. The procedure for this experiment was identical to
that in section 3.7.1 with the exception of increasing the water volume to 500ml. CRBPs were
added to 500ml of CP water and allowed to release for 24 hours and come up to room
temperature. A pure CP water control was used. Forty-five pill cups in all were separated into
three groups of fifteen, one set of fifteen for Prep A, one set of fifteen for Prep B and one set for
Prep C. With a pipette, 10ml sample stock solution was added to each pill cup. Test organisms
were then added. Treatments were labeled as shown in Table 3.5 and observed for 2 days.
Results were recorded every 24 hours and organisms were fed every other day.
Table 3.5
Labels for Treatments and Concentrations Tested with KMnO4 CRBP vs. Oxone® CRBP

CP

Test Volume
(ml)
500

Test Duration
(d)
2

Release Time
(hr)
−

Prep B: KMnO4 CRBP

CP

500

2

24

Prep C: Oxone® CRBP

CP

500

2

24

Treatment

Water Type

Prep A: Untreated Control
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3.7.3. Toxicity of KMnO4 CRBP vs. Oxone® CRBP in 600ml. Toxicity testing
continued with increasing the water volume. The procedure for this experiment was identical to
that reflected in section 3.7.1 with the expectation of using both spring water and CP water.
Spring water was incorporated under the assumption that it may provide a better environment for
test organisms and to observe if there will be a difference in results than from previous
experiments. The water volume was increased to 600ml for each water type. After formulation,
CRBPs were allowed to release in the water for 24 hours and reached room temperature. A pure
spring water and pure CP water control was used. Prep A received pure spring water while Prep
B received pure CP water. Sixty pill cups in all were separated into six groups of ten, two sets of
ten for control’s A and B and four sets of ten for each treatment Prep C-Prep F. With a pipette, a
10ml sample stock solution was taken from each treatment and placed into pill cups. Test
organisms were then added. Treatments were labeled as shown in Table 3.6 and observed for 4
days. Results were recorded every 24 hours and organisms were fed every other day.
Table 3.6
Labels for Treatments and Concentrations Tested with KMnO4 CRBP vs. Oxone® CRBP

Spring

Test Volume
(ml)
600

Test Duration
(d)
4

Release Time
(hr)
−

CP

600

4

−

Prep C: KMnO4 CRBP

Spring

600

4

24

Prep D: Oxone® CRBP

Spring

600

4

24

Prep E: KMnO4 CRBP

CP

600

4

24

Prep F: Oxone® CRBP

CP

600

4

24

Treatment

Water Type

Prep A: Untreated Control
Prep B: Untreated Control
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3.7.4 Toxicity of KMnO4 CRBP vs. Oxone® CRBP in 700ml. The treatments used
in this experiment were based on results from the previous experiment in Table 3.6. The volume
of water was increased to 700ml. The goal was to compare the previous data with identical
controls and treatments with a larger volume of water. After formulation of CRBPs as described
in section 3.2, polymers were placed in waters and allowed to release for 24 hours. Water was
allowed to reach room temperature during this time. Sixty pill cups in all were separated into six
groups of ten, two sets of ten for control’s A and B and four sets of ten for each treatment. With
a pipette, 10ml sample stock solution of each treatment and was taken added to each pill cup.
Test organisms were then added. Treatments were labeled as shown in Table 3.7 and observed
for 3 days. Results were recorded every 24 hours and organisms were fed every other day.
Table 3.7
Labels for Treatments and Concentrations Tested with KMnO4 CRBP vs. Oxone® CRBP

Spring

Test Volume
(ml)
700

Test Duration
(d)
3

Release Time
(h)
−

CP

700

3

−

Prep C: KMnO4 CRBP

Spring

700

3

24

Prep D: Oxone® CRBP

Spring

700

3

24

Prep E: KMnO4 CRBP

CP

700

3

24

Prep F: Oxone® CRBP

CP

700

3

24

Treatment

Water Type

Prep A: Untreated Control
Prep B: Untreated Control

3.7.5 Toxicity of KMnO4 CRBP in 700ml after 24h, 48h, and 72h Release.
Another toxicity test allowed the polymer to release for 24h, 48h and 72h in 700ml CP water.
Table 3.8 lists the time frames the CRBPs were allowed to release. According to Table 3.8, each
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polymer treatment was placed in 700ml CP water. The water was allowed to come up to room
temperature. Depending on the time frame, the polymer was left to release with the water for
24h, 48h or 78h and then the polymer was removed. The polymer was removed because any
further reactions taking place between the water and the treatment were not desired. Ninety pill
cups in all were separated into six groups of ten, three sets of ten for controls and three sets of
ten for each treatment. With a pipette, a 10ml sample of stock solution was taken from the 24h,
48h or 72h solution and was placed in each designated pill cup. Test organisms were then added.
Treatments were labeled as shown in Table 3.8 and observed from 6-8 days. Results were
recorded every 24 hours and organisms were fed every other day.
Table 3.8
Labels for Treatments and Concentrations Tested with KMnO4 CRBP: 24h, 48h, and 72h
Release

CP

Test Volume
(ml)
700

Test Duration
(d)
8

Release Time
(h)
−

Prep B: KMnO4 CRBP

CP

700

8

24

Prep C: Untreated Control

CP

700

7

−

Prep D: KMnO4 CRBP

CP

700

7

48

Prep E: Untreated Control

CP

700

6

−

Prep F: KMnO4 CRBP

CP

700

6

72

Treatment

Water Type

Prep A: Untreated Control

3.7.6 Toxicity of KMnO4 CRBP vs. Oxone® CRBP in 700ml for 72h Release. The
experiment was conducted similar to section 3.7.4 with the exception of CRBPs allowing to
release for 72 hours as oppose to only 24 hours. To determine any toxicological effects that the
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CRBP treatments might have on D. magna in 700ml of CP water, CRBP were formulated as
described in section 3.2. According to Table 3.9, each polymer treatment was placed in 700ml
CP water and was allowed to release for 72 hours. At this point water was also allowed to reach
room temperature. After 72 hours, polymers were removed from water. Thirty pill cups in all
were separated into three groups of ten; one set of ten for the control, one set of ten for treatment
B and one set of ten for treatment C. With a pipette, a 10ml sample of stock solution was taken
from the 72h release solution and placed in each pill cup. Test organisms were then added.
Treatments were labeled as shown in Table 3.9 and observed from 6 days. Results were recorded
every 24 hours and organisms were fed every other day.
Table 3.9
Labels for Treatments and Concentrations Tested with KMnO4 CRBP vs. Oxone® CRBP
Treatment

Water Type

Prep A: Untreated Control

CP

Test Volume
(ml)
700

Test Duration
(d)
6

Release Time
(h)
−

Prep B: KMnO4 CRBP

CP

700

6

72

Prep C: Oxone® CRBP

CP

700

6

72

3.7.7 Toxicity of KMnO4 CRBP in 800ml, 900ml and 1000ml. After conducting
toxicity of KMnO4 CRBP vs. Oxone® CRBP in 700ml for 24 hours (section 3.7.5), increasing
the concentrations to 800ml, 900ml and 1000ml was performed. This was done in order to
investigate the outcome of D. magna toxicity with CRBPs and increased water volume.
Similarly, after being formulated, each polymer treatment was placed in all three volumes of CP
water and was allowed to release for 24 hours. Ninety pill cups in all were separated into six
groups of fifteen; three sets of fifteen for the controls, three sets of fifteen for the treatments.
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With a pipette, a 10ml sample of stock solution was taken from the 24h release solution and
placed in each pill cup. This was done for every volume. Test organisms were then added.
Treatments were labeled as shown in Table 3.10 and observed from 6-8 days. Results were
recorded every 24 hours and organisms were fed every other day.
Table 3.10
Labels for Treatments and Concentrations Tested with KMnO4 CRBP 24h Release

CP

Test Volume
(ml)
800

Test Duration
(d)
8

Release Time
(h)
−

Prep B: KMnO4 CRBP

CP

800

8

24

Prep C: Untreated Control

CP

900

7

−

Prep D: KMnO4 CRBP

CP

900

7

24

Prep E: Untreated Control

CP

1000

6

−

Prep F: KMnO4 CRBP

CP

1000

6

24

Treatment

Water Type

Prep A: Untreated Control

3.8 Trial III: A Time-Based Experiment
Given the results from the toxicity to D. magna in previous experiments, a time-based
toxicity test was performed. The test would track the treated water affects each hour. 700ml of
CP water was used prepared. The CRBP was formulated identical to previous experiments. The
polymer was left to release in water for 24h, and then it was removed. Fifty pill cups in all were
used to shown in Figure 3.5. With a pipette, a 10ml of sample stock solution was added to each
pill cup. Test organisms were then added. Data was recorded every hour from the time the first
organism was placed inside the chambers. Data was collected until there was no sign of survival.
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Table 3.11
Label for Treatment and Concentration Tested for Time-Based Experiment
Treatment

Water Type

Test Volume (ml)

Test Duration (h)

Oxone® CRBP

CP

700

3

3.9 Statistics
Statistical analysis was performed using GraphPad© Prism Software, Inc. Differences
among treatments were analyzed by one-way analysis of variance (ANOVA), taking p<0.05 as
significant and two-way ANOVA, taking p<0.01 as significant. Bonferroni’s multiple
comparison tests were used as a post-test to further investigate significant values. One-way
ANOVA for KMnO4 was performed to observe a significant difference between the controls and
treatments throughout this study. Trial 1 (a) and (b) used one-way ANOVA taking p<0.05 as
significant to compare the control 0.5g PCL + 0.1g KMnO4 and the control verses 0.5g PCL +
0.3g Oxone®. Trial II toxicity used the one-way ANOVA to compare; (1) KMnO4 CRBP verses
Oxone® CRBP in 700ml CP water after 24h release compared the (2) control verses Oxone®
CRBP, (3) Oxone® CRBP in spring water verses KMnO4 CRBP in CP water and (4) KMnO4
CRBP in CP water vs. Oxone® CRBP in CP water. Trial II continues to use the one-way
ANOVA to compare the toxicity of KMnO4 CRBP vs. Oxone® CRBP in 700ml of CP after 72h
release compared (1) KMnO4 CRBP vs. Oxone® CRBP. A Two-Way ANOVA for KMnO4
CRBP to note a significant difference between 24h, 48h and 72h release. A comparison between
24h vs. 48h release of the KMnO4 CRBP and 24h vs. 72h release of KMnO4 CRBP was
conducted using p value<0.01 for the two-way AVOVA.
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CHAPTER 4
Results and Discussion
4.1 Controlled Release Experiments Using CRBP
The study of KMnO4 CRBP and Oxone® CRBP released over time and exposed to D.
magna was investigated. It was hypothesized that the CRBP could be a potential treatment
technology to treat natural surface waters without toxicity to aquatic life. The oxidants were
encapsulated inside PCL and placed in 100ml-1000ml of spring water or CP water. Figure 4.1
shows an example of the oxidants diffusing from the polymer after they were placed in water.
For this thesis, experiments were divided into three trials. Trial I was performed to show (a) the
toxicity of pure PCL to D. magna and (b) to show the toxicity of oxidants without encapsulation.
In Trail II, all experiments conducted were to show toxicity of oxidant encapsulation, KMnO4
CRBP and Oxone® CRBP when exposed to D. magna at different volumes and released over
different time frames. Finally, Trail III shows a time-based experiment to see the toxicity of
Oxone® CRBP to D. magna on an hour-by-hour basis. Raw data for the experiments is available
in the Appendix.

(A)

(B)
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Figure 4.1 Initial release of (A) KMnO4 CRBP and (B) Oxone® CRBP Released in Water
4.2 Toxicity of CRBP to D. magna
D. magna is the most commonly used non-target aquatic species used in toxicology tests.
They are used for a wide range of purposes including assays for pure materials and complex
industrial discharges. The data obtained in literature often suggests that D. magna are among the
most sensitive aquatic organisms tested. Therefore, the results in these experiments will be used
to determine safe concentration levels of CRBPs for the treatment of contaminated or impaired
water systems. In these experiments, the number of mobile D. magna was recorded at the end of
every 24h period. D. magna that did not move within 15 seconds, following a gentle agitation of
the pill cup, were considered immobilized or dead.
4.3 Trial I
4.3.1 Trial I (a) D. magna exposure to 0.5g PCL in CP water. PCL and oxidants
including KMnO4 and Oxone® in pure form were released for 24h in separate beakers, each
containing 100ml of CP water. Oxidants were not encapsulated in order to see the impact of the
full concentration. Concentration amounts previously mentioned in chapter 3, Table 3.2 were
measured using a laboratory scale. Figure 4.2 shows 0.5g PCL compared to the control
indicating more than 90% survival. The PCL material itself does not appear to be toxic to D.
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magna in the lowest volume (100ml) of water tested. Statistical analysis confirms this result
showing no difference between the control and the PCL as seen in Table 4.1. These findings
confirm PCL would not pose a potential threat in aquatic systems as the stabilizing material for
oxidant encapsulation.

Figure 4.2 Impact of 0.5g PCL and pure oxidants KMnO4 and Oxone®
4.3.2 Trial I (b) D. magna exposure to oxidants without encapsulation. In addition
to preliminary experiments with PCL, the oxidants KMnO4 and Oxone®, in pure form, were
exposed to D. magna. The data indicated in Figure 4.2 shows that 99.9% of D. magna treated
with pure KMnO4 and Oxone® in 100ml of control waters died after day 0. With respect to the
control, there is a significant difference between both oxidant treatments (Table 4.1). Increased
toxicity was observed in the samples without encapsulation with the potential to kill aquatic
organisms within a water body being treated by Oxone®.
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Table 4.1
Bonferroni’s Multiple Comparison Results for D. magna Exposed to Trial I
Mean

Significant?

Diff.

P < 0.05?

2.167

No

ns

-6.342 to 10.68

9.167

Yes

*

0.6582 to 17.68

9.583

Yes

*

1.075 to 18.09

Treatment
Control vs. 0.5g PCL

95% CI of
Summary
diff.

Control vs. 0.5g PCL + 0.1g
KMnO4
Control vs. 0.5g PCL + 0.3g
®

Oxone

The potential toxicity of KMnO4 compound recorded by Hobbs et al. (2006) solidifies the results
achieved in KMnO4 experiment. KMnO4 (without encapsulation) in Hobbs et al. (2006) was
identified as having a high degree of toxicity to ﬁsh, which are classified as a higher aquatic
organism than D. magna. KMnO4, due to its strong oxidant nature, caused damage to delicate
tissues like skin and gills in fish. The degree of damage to tissues was dependent upon the
KMnO4 concentration (Darwish et al. 2002). Similarly, França et al. (2001) reported that the
toxicity of KMnO4 performed with the microcrustacean cladoceran C. dubia, which is a species
similar to D. magna. Acute toxicity occurred after 24 hours of exposure with KMnO4
concentrations of 0.25 mg/L of KMnO4.
4.4 Trail II
All experiments conducted in Trial II were to show toxicity of oxidant encapsulation,
KMnO4 CRBP and Oxone® CRBP when D. magna are exposed at different volumes and varying
exposure times. High mortality rates occurred with Oxone® CRBP treated water within 24h.
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When compared to Oxone® CRBP, KMnO4 CRBP exposures appeared to have better survival
rates. Trial II experiments will show these results.
4.4.1 Toxicity of Oxone® CRBP 24 hour release in 300ml CP water. Test organisms
were exposed to Oxone® CRBP after it was released in 300ml of CP water for 24h. Figure 4.3
shows the impact of Oxone® CRBP to D. magna over a 2 day period. When comparing the
control to the Oxone® treatment, it is evident that the survival rates are extremely different.
While the control appears to have remained constant throughout the duration of testing, 100% of
D. magna exposed to Oxone® CRBP died after day 0. Further experimentation will identify the
cause of rapid and excessive mortality rates of D. magna in an Oxone® CRBP environment.

Figure 4.3 Impact of Oxone® in 300ml CP water 24h release
4.4.2 Toxicity of KMnO4 CRBP vs. Oxone® CRBP 24h release in 500ml CP water.
To further investigate the outcome of toxicity testing performed in Figure 4.3. CP water was
increased in volume from 300ml to 500ml. It was hypothesized that D. magna survival would
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increase in a larger volume of water containing the Oxone® CRBP. As shown in Figure 4.4, the
impact of the Oxone® CRBP once again resulted in 100% mortality (n = 64).

Figure 4.4 Impact of KMnO4 CRBP vs. Oxone® CRBP in 500ml CP water 24h release
The controls began to die as seen in Figure 4.5. The control and KMnO4 treatment
relationship is very close on day 1, going from n=44 D. magna in the control to n=15. For the
KMnO4, the initial n=57 decreased to n=16. These results led to question if there were problems
with toxicity of the CP water more than the oxidant. Perhaps the samples of CP water collected
contained chemicals or substances that were not conducive to D. magna. Country Park Lake does
not currently have a population of D. magna growing in the water but does have higher-level fish
that are added to the lake for public fishing and recreational purposes. Country Park Lake
receives water from a number of sources from the watershed including run-off, groundwater
from a nearby park, neighborhoods, or surrounding industrial areas that could impair the
waterway.
In support of this claim, the City of Greensboro reported the 2012 Water Quality Results
Monitored Leaving The Treatment Plant table that summarized a number of contaminants and
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their potential sources found in Greensboro lakes. Manganese, induced by landfill and cropland
runoff as well as deposits occurring naturally was found. Synthetic organic chemicals such as
pesticide and herbicide runoff and discharge from rubber & chemical factories were also
indicated, and total trihalomethanes (TTHM) by-products of drinking water disinfection was
recorded. The report notes that some people who drink water containing trihalomethanes in
excess of the MCL (the highest level of a contaminant that is allowed in drinking water) over
many years may experience problems with their liver, kidneys, or central nervous systems, and
may have an increased risk of getting cancer. (City of Greensboro, 2012). Since D. magna are
not found in Country Park surface water, chemicals and substances in the CP water could have
been present in water samples leading to high D. magna mortality.
Table 4.4 shows comparisons between treatments and controls. The relationships indicate
no significant difference, sharing comparable probabilities that more than 80% of the population
will die. In assessing the importance of this result, it is the size of the effect not just the size of
the significance that matters. The size of the effect related to Oxone® CRBP and CP water is
significant and the observed data is consistent throughout testing with as much as 90% mortality
after 24h in these exposure.
Table 4.2
Bonferroni's Multiple Comparison Test Results of CRBPs release in 5ooml CP water
Treatment
Control vs. KMnO4 CRBP:

Mean Significant?
Diff. P < 0.05?
0
No

Summary

95% CI of diff

ns

-75.73 to 75.73

Control vs. Oxone® CRBP:

5.333

No

ns

-70.40 to 81.06

KMnO4 CRBP vs. Oxone® CRBP

5.333

No

ns

-70.40 to 81.06
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4.4.3 Toxicity of KMnO4 CRBP vs. Oxone® CRBP 24h release in 600ml CP water.
As seen in Figure 4.4, perhaps sample CP water used in Figure 4.5 contained similar substances
that caused significant mortality since the same sample water was used in both experiments.
Figure 4.5 depicts D. magna experiencing 100% mortality in three out of four treatments which
included KMnO4 CRBP in spring water, Oxone® CRBP in spring water, and Oxone® CRBP in
CP water. The two Oxone® CRBP treatments had 100% mortality after day 0. Controls also
show declining D. magna survival decreasing from n=10 in the spring water control to n=0 and
from n=12 in the CP water control to n=3 after 4 days of exposure. Since this is a static, nonrenewal toxicity test, the test organisms are exposed to the same test water for the duration.
Therefore, the belief was that CP water could be the reason for more than 50% mortality in the
CP water control after day 3.

Figure 4.5 Impact of KMnO4 CRBP vs. Oxone® CRBP in 600ml CP water 24h release
However, it is possible to incorporate additional information that will aid in the interpretation of
test results. Therefore, spring water was incorporated as an additional water type used in the
experiments to confirm this assumption. The spring water control did not perform as well when
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compared to the CP water control. Figure 4.5 also shows all treatments containing Oxone®
CRBP and/or spring water had an immediate negative effect on D. magna survival with more
than 50% mortality. Because the Oxone® CRBP exhibits identical behavior in spring water and
in CP water, this suggests that chemical effects may be a contributor to 100% D. magna
mortality. The chemical structure of the oxidant makes it highly capable of inducing DNA
damage or producing binds to single-stranded DNA, causing strand scission in specific areas of a
guanine site (Sánchez-Fortún et al. 2008). This supports the outcome in this study, suggesting
DNA denaturation is the source of mortality in non-target organisms when exposed to
strengthened oxidants such as Oxone®. KMnO4 CRBP in CP water seemed to perform better than
any other treatment with slight decline in survival over a 4 day period.
4.4.4 Toxicity of KMnO4 CRBP vs. Oxone® CRBP 24h release in 700ml CP water.
In figure 4.6, Oxone® CRBP again showed high toxicity with 100% mortality observed within
the first 24h. Since the reason for mortality has been assessed in the previous experiment (4.4.3),
looking at the Oxone® CRBP releasing for a longer period of time to achieve higher mortality
rates will follow. In treatments with KMnO4 CRBP in spring water, high mortality rates were
recorded with n=17 at day 0 to n=1 at the end of day 1 exposure. This confirms that spring water
does not provide a desired environment for D. magna as seen in previous experiments. This
could be due to spring water lacking the natural components that appear in an environment
where D. magna are found. In addition, Figure 4.6 shows small changes in D. magna recovery
in KMnO4 spring water were noted at day 1 with n=5 by the end of testing. Hobbs et al. (2006)
observed similar results after a static 96h pure KMnO4 exposure to species of fish.
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Figure 4.6 Impact of KMnO4 CRBP vs. Oxone® CRBP in 700ml CP water 24h release
When comparing between KMnO4 CRBP in spring water and KMnO4 CRBP in CP water, there
is a significant difference. Surprising, the CP water control remains constant throughout the
duration of this experiment. Although this is the same sample CP water that was used in previous
experiments, it appears to becoming a suitable environment with almost a 40% increase in D.
magna survival and experiencing reproduction within the initial 24h exposure period.
4.4.5 Toxicity of KMnO4 CRBP 24h, 48h and 72h release in 700ml CP water.
Results gained from Figure 4.6, where a slight increase in KMnO4 exposed D. magna survival
begins to occur led to the curiosity of what would happen if the KMnO4 CRPB was allowed to
release for longer periods of time. Figure 4.7 shows KMnO4 CRBP in 700ml of CP water for
24h, 48h and 72h, respectively. During the exposure period n=10 for CP water control going to
n= 10 and n=10 for KMnO4 CRBP in CP water to n=1 after 8 days of exposure. Figure 4.7 I.
shows CP water control and 24h release of KMnO4 CRBP are similar from day 1-3, but after day
3, the KMnO4 treatment began to die faster.
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I.

II.

III.
Figure 4.7 Impact of KMnO4 CRBP vs. Oxone® CRBP in 700ml CP water 24h-78h
According to (Francis-Floyd & Klinger, 2009), KMnO4 is an oxidizing agent capable of
reacting with any organic material present in the water, including bacteria, fungi and other
parasites. This can cause substances that are easily oxidized to rapidly decrease the activity of
KMnO4 and this initial demand on the compound decreases its effective concentration (Franca et
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al 2011). Figure 4.8 is a photo of the watercolor change from pink to brown due to the formation
of manganese dioxide (MnO2). MnO2 is a product of the reduction of KMnO4 (Franca et al.
2011). Therefore, this explains the high mortality rates achieved in previous experiments. As
seen in Figure 4.6 and Figure 4.7 (I), the first hours of the experiment, the small amount of
organic matter present had little effect on KMnO4 toxicity, which explains the high mortality rate
in the initial period of 24h exposure (Franca et al. 2011).

(A)

(B)

Figure 4.8 Change in water color (A) initial KMnO4 (B) KMnO4 CRBP after 24h release
Compared to Figure 4.7 I, Figure 4.7 II and Figure 4.7 III show improvement in D. magna
survival and reproduction rates when the release time is extended from 24h to 48h and 72h. In
Figure 4.7 II and Figure 4.7 III, the KMnO4 CRBP mimics the CP water control, which is a
desirable effect. Figure 4.7 II (48h release) and Figure 4.7 III (72h release) behaviors suggest
neither the water nor the CRBP negatively impacts the organisms with n=37 for CP increasing to
n=75 by day 7 due to reproduction of the D. magna during the experiment. For KMnO4 CRBP in
CP water starting with n=32 D. magna increased to for to n=61 by day 7. This is almost a 30%
increase in survival when the KMnO4 CRBP release when the 48h survival and reproduction
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rates are compared to the 24h survival and reproduction rates. Reproduction is an important
outcome because D. magna reproduction has an impact on population of the organism and food
web dynamics in aquatic systems. In Figure 4.7 III D. magna behaviors also demonstration
positive results with n=23 for CP water control at day 0 to n=59 by day 7 and n=25 for KMnO4
CRBP in CP water to n=82. This exhibits almost a 60% increase in survival when KMnO4 CRBP
release occurs for 72h compared to 48h and 24h. KMnO4 treatments appear to perform better
when CRBP is allowed to release for longer periods of time before being exposed to organisms.
Both KMnO4 CRBP treatments after 48h and 72h release followed the same trend as the
untreated CP water control by producing offspring that mimic the reproduction of the control.
This suggests that KMnO4 CRBP is not harmful to non-target aquatic organisms if the treated
water is held for 48h or 72h before being released into the environment. Figure 4.9 shows a TwoWay ANOVA conducted to perform a dose and time effect study of 24h, 48h and 72h release of
KMnO4 CRBP in CP water. This experiment confirmed if extended release time frames of the
CRBP would yield higher D. magna survival, increased reproduction, and effective remedial
treatment.

Figure 4.9 Two-Way ANOVA for KMnO4 CRBP Toxicity for 24h, 48h, and 72h Release
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In Hobbs et al. (2006), used 5-10 organisms for their study whereas for this thesis
research used 10-20 organisms. Both this thesis and Hobbs et al. (2006) used D. magna and the
same statistical model with the one-way ANOVA for statistical analysis. Both studies used
KMnO4 performed used similar organisms, and the same statistical model with one-way
ANOVA statistical analysis to notes significant differences between treatments. The two studies
were performed also used KMnO4. Hobbs et. al (2006) and this studied 3-day acute toxicity
testing whereas this study observed 6-8 day acute toxicity testing. Similar findings were obtained
between the two studies for KMnO4. A significant difference between this study and Hobbs et al.
(2006) shows that KMnO4 left treated at an extended period of time will result in greater D.
magna survival as well as increased reproduction. Hobbs et al. (2006), however, did not observe
reproduction occurrences.
4.4.6 Toxicity of Oxone® CRBP 72h release in 700ml CP water and Toxicity of
KMnO4 CRBP vs. Oxone® CRBP 72h release in 700ml CP water. The toxicity of KMnO4
CRBP versus Oxone® CRBP 24h release in 700ml CP water is presented in Figure 4.11 (A). This
figure shows Oxone® CRBP released for 72h to determine if the retention time of 72 H would
improve D. magna survival. In Figure 4.10 (B) when comparing KMnO4 CRBP in CP water to
Oxone® CRBP in CP water, there is a significant difference also shown in Table 4.7. KMnO4
CRBP is 100% more likely to have better survival results. As seen in previous experiments in
this study, Oxone® continues to exhibit 100% mortality regardless of the volume of water used.
In Figure 4.10 (B), Oxone® CRBP also proves that it will exhibit 100% mortality regardless of
the release time. This suggests this form of treatment should not be exposed in water systems
where aquatic life is present. In Figure 4.10 (B), by day 5, more than a 50% increase in D. magna
survival is seen within KMnO4 CRBP treatment compared to 0% survival for Oxone® CRBP
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treatment. This is a viable form of treatment and with increased release time periods present
minimal effects to non-target organisms.

(A)

(B)

Figure 4.10 The impact of Oxone® CRBP in 700ml CP water after 72h
Table 4.3
Bonferroni's Multiple Comparison Test Results for CRBPs 72h Release in 700ml water
Mean
Diff.
-4.2

Significant?
P < 0.05
No

1

Control: CP vs. Oxone® CRBP: CP
KMnO4 CRBP: CP vs. Control: CP

Treatment
Control: CP vs. KMnO4 CRBP
Control: CP vs. Control: CP

KMnO4 CRBP: CP vs. Oxone®

Summary

95% CI of diff

ns

-16.78 to 8.381

No

ns

-11.58 to 13.58

12.2

No

ns

-0.3812 to 24.78

5.2

No

ns

-7.381 to 17.78

16.4

Yes

**

11.2

No

ns

3.819 to 28.98

CRBP: CP
Control: CP vs. Oxone® CRBP: CP

-1.381 to 23.78
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4.4.7 Toxicity of KMnO4 CRBP vs. Oxone® CRBP 24h release in 800ml, 900ml and
1000ml CP water. Figure 4.11 shows KMnO4 release for 24h in 800ml, 900ml and 1000ml.
This was done to see if increasing the volume of water would make a difference in D. magna
survival. Figure 4.11 I. and II. appear similar from 0-7 days. When culturing D. magna, test
organisms have to become acclimated to the new environment. Figure 4.11 I and II show
KMnO4 mimicking the CP water control until day 8, after which the control exhibits extremely
high rates of reproduction. Despite this increase, the KMnO4 trend line stays relatively constant.
Testing 800ml, 900ml and 1000ml CP water with KMnO4 CRBP took place at the same time.
For this reason, questions arise when comparing Figure 4.11 I and II with Figure 4.11 III. The
later results show various factors that could be the reason why the treatment that caused
unexpected results.
It is not always possible to identify any particular isolated test outcome at the conclusion
of an experiment due to a number of potential factors, both known or unknown, that could
impact the results (EPA, 2000). For example, quality assurance (QA) information can be used to
assess the overall quality of the test system (i.e. test facility, culture procedures, test
maintenance, skill of the researcher, etc.). Small significant effects may be more difficult to
verify hence the need for follow-up testing.
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I.

II.

III.
Figure 4.11 Impact of KMnO4 CRBP vs. Oxone® CRBP in 800ml, 900ml and 1000ml CP water
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4.4.8 Toxicity of Oxone® CRBP 24h release in 700ml CP water. Oxone® CRBP was
investigated to determine the cause of high mortality when exposed to D. magna. Previous
studies concluded that Oxone® encapsulated CRBP should release at a rate of 0.011 grams per
day (Rogers, 2012). For a time-based study, Oxone® CRBP was released in 700ml of CP water
for 24h. Figure 4.12 presents the toxicity of Oxone® to D. magna. A large sample size (n=59) of
test organisms was used to demonstrate the strength of Oxone®. As shown in Figure 4.12, within
a 3h period of time all test organisms died (100% mortality).

Figure 4.12 Impact of Oxone® CRBP in 700ml CP water hour-by-hour
Within the 3h exposure period, D. magna went through three phases before reaching
100% mortality. In the first phase, sporadic swimming and increased escape maneuvers were
observed. In the second phase, movement became less continuous and began to slow down
throughout the testing period. In the third phase, D. magna exhibited lightening in color, almost
becoming white, and began to undergo a bleaching effect. Sánchez-Fortún et al. 2008 soldifies
the reults obtained in this experiment by discovering that when RTG-2 cells derived from
rainbow trout were exposed to Oxone®, DNA from control cells were denatured after 30 minutes.
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The authors also found that with respect to Oxone® assays, any concentration used exhibited a
statistical different response with respect to DNA denaturation control curves. Similarly, Ross
and Burrows (1996) studied bromination of cytosine and the formation of a piperidinelabile site
using simple salts such as Oxone®. They observed that when Oxone® was allowed to react with
single-stranded oligodeoxynucleotides, a simple cytosine-specific reaction utilizing Oxone® lead
to scission of single-stranded DNA after piperidine treatment. This solely confirms that Oxone®
oxidants or Oxone® CRBP should not be used directly in water systems where aquatic life is
present.

Figure 4.13 The impact of Oxone® CRBP in 700ml CP water hour-by-hour
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CHAPTER 5
Conclusion and Future Research
The KMnO4 CRBP and Oxone® CRBP toxicity test using D. magna represents an initial
investigation into the possible toxic effects of KMnO4 and Oxone® treatment within an
encapsulated biodegradable polymer structure. The Whole Effluent Toxicity (WET) test
demonstrated that as the CRBP exposure time increased, the toxic effects to non-target aquatic
organisms were observed to decrease for KMnO4 CRBP. PCL appeared not to be toxic to D.
magna and confirming encapsulation of oxidants within this structure has the potential to reduce
oxidants’ potential toxic effects. The WET test also suggested that the Oxone® CRBP hindered
D. magna growth in natural waters. Oxone® in this study consistently led to death of the test
organisms, which is consistent with the results from Sanchez-Fortun et al. (2008) where Oxone®
caused DNA damage to test organisms. The Oxone® CRBP resulted in 100% mortality in
volumes ranging from 100ml to 1000ml of test waters and up to a 72h release time periods. The
result obtained from this study provides evidence that Oxone® is not suitable for natural waters
which may contain aquatic life and freshly treated water with Oxone® should not be released
directly into the environment. Oxone® CRBP treatment would be more suitable as a contained or
controlled industrial water or wastewater treatment process. Examples that would be feasible for
Oxone® CRBP include wastewater treatment facilities, swine farms, environmental treatment
facilities, lagoons, or any water system environment where no aquatic life will directly receive
treated effluent water earlier than a 48 hour retention time.
KMnO4 CRBP exhibited signs that the oxidant treatment, when encapsulated, does not
significantly alter the survival or reproduction of D. magna. KMnO4 CRBP treated water,
demonstrated minimum impact on D. magna based on treatment volume and retention time for
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48 to 72 hours. KMnO4 CRBP released in Country Park water demonstrated the best survival
when compared to the control out of all the treatments in 700ml to 1000ml volumes from 48h to
72h CRBP release time period. Undesirable results observed at lower water volume levels and at
shorter release times may have been attributed to a relativity high initial release rate of the
KMnO4 from the polymer structure. In the case of KMnO4, manganese dioxide formation of
KMnO4 in aqueous solution decreased D. magna survival. The results of this work can help to
determine which water treatment system would be best for aquatic life using either KMnO4
CRBP or Oxone® CRBP to treat contaminated water systems.
In this study, surface water collected from Country Park Lake in Greensboro, NC offered
better testing source water for the research study. Data obtained from this thesis may be used in
future research to further study the potential effects of the technology on non-target organisms.
The CRBP technology serves as a potential method to treat water, provided the limitations for
the oxidants are considered. For example, KMnO4 will turn treated waters purple whereas
Oxone® has high oxidation strength. Although the formation of manganese dioxide when
KMnO4 is in aqueous solution is produced, this positive chemical reaction has the ability to turn
the water from a purple or pink color to a more brown color, which will possibly appear normal
when released in treated waters. Oxone®, as a treatment method, should be used in a controlled
system and waters should be contained and not released directly into surface water; however,
treated water can be applied for irrigation or water reuse on-site.
Further research is needed to: (1) Determine toxicity of Oxone® within wastewater
systems; (2) determine the amount of CRBP to use for a particular size water body that requires
treatment; (3) conduct more time based experiments using Oxone® CRBP at 48h and 72h time
frames to see what happens on a time scale; and (4) conduct additional toxicity tests at different
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CRBP release time frames in different volumes of test waters. The data obtained in this study
should be used to test bacteria levels that would remain exposed for 24h in 800ml, 900ml,
1000ml and higher of CP water and measure how much E coli and enterococci remains after 7 or
8 days; and determine if the type of test water, depending on bacteria present, will affect the
predetermined release rate of the CRBP.
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Appendix
Table A.1
D. magna Survival (n) for Trial I (a) & (b)
24h Treatment
Day
0
1
2
3

Control: CP
10
13
15
23

10
8
10
15

0.036g PCL
10
10
10
11

11
11
11
10

10
10
10
10

10
10
8
8

0.5g PCL + 0.1g
KMnO4
10
11
10
0
0
2
0
0
1
0
0
1

0.5g PCL + 0.3g
Oxone®
10
10
10
0
0
0
0
0
0
0
0
0

Table A.2
Oxone® CRBP Impact to D. magna (n) in 300ml CP water for 24h
24h Treatment
Day
0
1
2

35
35
33

Control
35
35
32

26
25
20

Oxone® CRBP: CP Water
35
35
28
0
0
0
0
0
0

Table A.3
KMnO4 CRBP vs. Oxone® CRBP Impact to D. magna (n) in 500ml CP water for 24h
24h Treatment
Day
Control: CP
n
0
44
1
15
2
18

KMnO4 CRBP: CP
n
57
16
7

Oxone® CRBP: CP
n
64
0
0
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Table A.4
KMnO4 CRBP vs. Oxone® CRBP Impact to D. magna (n) in 700ml CP water for 24h
24h Treatment
Control:
Day
Spring
0
1
2
3

13
11
11
12

Control:
CP
17
13
17
13

KMnO4
CRBP:
Spring
17
1
4
5

Oxone®
CRBP:
Spring
12
0
0
0

KMnO4
CRBP:
CP
15
21
23
14

Oxone®
CRBP:
CP
14
0
0
0

Table A.5
KMnO4 CRBP Impact to D. magna (n) in 700ml CP water for 24h, 48h and 72h
24h Treatment
Day
0
1
2
3
6
7
8
48h Treatment
Day
0
1
2
5
6
7
72h Treatment
Day
0
1
4
5
6

Control: CP
10
7
7
6
5
4
3

KMnO4 CRBP: CP
10
8
7
6
3
1
1

Control: CP
37
30
32
42
54
75

KMnO4 CRBP: CP
32
31
30
40
48
61

Control: CP
23
23
28
27
59

KMnO4 CRBP: CP
25
26
40
62
82

72

Table A.6
KMnO4 CRBP Impact to D. magna (n) in 800ml, 900ml and 1000ml CP water for 24h
800ml
Day

Control: CP

0
1
4
5
7
8
11
12

25
25
22
22
21
21
150
147

900ml
KMnO4
CRBP:
CP
36
35
36
24
17
16
24
21

1000ml

Control:
CP

KMnO4
CRBP: CP

Control:
CP

KMnO4
CRBP: CP

30
26
25
25
25
26
42
45

38
36
34
29
18
26
25
26

30
29
21
14
10
10
2
2

40
38
37
28
23
23
13
13

Table A.7
Oxone® CRBP hour-by-hour Impact to D. magna (n) in 700ml CP for 24h
24h Treatment
Hour
0
1
2
3

56
26
1
0

Oxone® CRBP: Country Park
57
43
5
0

64
55
6
0

Table A.8
KMnO4 CRBP vs. Oxone® CRBP Impact to D. magna (n) in 600ml CP water for 24h
24h Treatment
Day
Control:
Spring
0
10
1
9
2
9
3
8
4
0

Control:
CP
12
16
17
14
3

KMnO4 CRBP:
Spring
11
0
0
0
0

Oxone® CRBP:
Spring
12
0
0
0
0

KMnO4 CRBP:
CP
14
11
9
6
1

Oxone® CRBP:
CP
11
0
0
0
0
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